SCHEMBL31437076

SCHEMBL31437076

COC(=O)c1cc(F)c(N2CCN(C(=O)OC(C)(C)C)CC2)cc1C#N

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 9/20 0.46
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.45
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.43
KMT2A Q03164 1/20 0.43
NR1H2 P55055 2/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
NR1H3 Q13133 1/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
NSD2 O96028 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22505342 1.00 GPR119 (0.46) GPR119ALDH1A1HTTMAPTKDM4E
SCHEMBL30798343 0.84 ALDH1A1 (0.60) ALDH1A1HTTMAPTKDM4EKMT2A
SCHEMBL24717493 0.84 ALDH1A1 (0.60) ALDH1A1HTTMAPTKDM4EKMT2A
SCHEMBL20521289 0.84 ALDH1A1 (0.47) GPR119ALDH1A1HTTMAPTKDM4E
SCHEMBL710593 0.84 GPR119 (0.53) GPR119ALDH1A1HTTMAPTNR1H2
SCHEMBL22505523 0.83 ALDH1A1 (0.47) GPR119ALDH1A1HTTMAPTKDM4E
SCHEMBL31437107 0.83 ALDH1A1 (0.47) GPR119ALDH1A1HTTMAPTKDM4E
SCHEMBL23703371 0.83 ALDH1A1 (0.47) GPR119ALDH1A1HTTMAPTKDM4E
SCHEMBL25691277 0.83 TSHR (0.49) ALDH1A1HTTMAPTKDM4EKMT2A
SCHEMBL22505542 0.81 ALDH1A1 (0.46) GPR119ALDH1A1HTTMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120152967-A Bifunctional compounds containing 2, 5-substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-06-13 CN disclosed
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed